Guillermo Ruiz Esparza Herrera, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanomedicine | 4 | 2021 | 304 | 1.110 |
Why?
|
| Nanostructures | 2 | 2021 | 551 | 0.920 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 235 | 0.710 |
Why?
|
| Pericardium | 1 | 2021 | 667 | 0.570 |
Why?
|
| Biocompatible Materials | 6 | 2021 | 1736 | 0.400 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 2219 | 0.400 |
Why?
|
| Liposomes | 1 | 2013 | 759 | 0.340 |
Why?
|
| Methacrylates | 2 | 2021 | 107 | 0.340 |
Why?
|
| Drug Carriers | 1 | 2013 | 693 | 0.320 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 1637 | 0.310 |
Why?
|
| Gelatin | 2 | 2021 | 225 | 0.300 |
Why?
|
| Nanoparticles | 2 | 2013 | 1905 | 0.240 |
Why?
|
| Hydrogels | 2 | 2021 | 724 | 0.230 |
Why?
|
| Heart | 1 | 2016 | 4467 | 0.210 |
Why?
|
| Polyesters | 2 | 2021 | 363 | 0.210 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2021 | 135 | 0.200 |
Why?
|
| Nanofibers | 1 | 2021 | 66 | 0.190 |
Why?
|
| Hernia, Abdominal | 1 | 2021 | 53 | 0.190 |
Why?
|
| Tissue Scaffolds | 3 | 2021 | 956 | 0.170 |
Why?
|
| Tropoelastin | 1 | 2017 | 29 | 0.160 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 968 | 0.150 |
Why?
|
| Adhesives | 1 | 2017 | 61 | 0.150 |
Why?
|
| Bioreactors | 1 | 2018 | 236 | 0.150 |
Why?
|
| Electrolytes | 1 | 2017 | 282 | 0.140 |
Why?
|
| Tissue Adhesives | 1 | 2017 | 179 | 0.130 |
Why?
|
| Tears | 1 | 2017 | 256 | 0.130 |
Why?
|
| Elasticity | 1 | 2017 | 657 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1182 | 0.130 |
Why?
|
| Silicon | 1 | 2016 | 145 | 0.130 |
Why?
|
| Rabbits | 1 | 2021 | 4894 | 0.120 |
Why?
|
| Tissue Engineering | 3 | 2020 | 1880 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2017 | 540 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18029 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 1420 | 0.110 |
Why?
|
| Fibronectins | 1 | 2017 | 726 | 0.110 |
Why?
|
| Wound Healing | 3 | 2021 | 2785 | 0.110 |
Why?
|
| Microfluidics | 1 | 2018 | 662 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7181 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 10900 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2021 | 1540 | 0.100 |
Why?
|
| Orthopedics | 1 | 2019 | 904 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2020 | 1901 | 0.090 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 828 | 0.090 |
Why?
|
| Polymers | 1 | 2016 | 1621 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 15165 | 0.080 |
Why?
|
| Oxygen | 1 | 2020 | 4189 | 0.080 |
Why?
|
| Animals | 11 | 2021 | 168757 | 0.070 |
Why?
|
| Sirolimus | 1 | 2014 | 1564 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 1708 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 3537 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2109 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.060 |
Why?
|
| Myocardium | 1 | 2016 | 4776 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3505 | 0.050 |
Why?
|
| Rats, Nude | 1 | 2021 | 105 | 0.050 |
Why?
|
| Engineering | 1 | 2021 | 58 | 0.050 |
Why?
|
| Cytochromes c | 1 | 2021 | 180 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5615 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2021 | 643 | 0.050 |
Why?
|
| Poloxamer | 1 | 2020 | 57 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2020 | 164 | 0.040 |
Why?
|
| Peroxides | 1 | 2020 | 74 | 0.040 |
Why?
|
| Rats | 3 | 2021 | 24260 | 0.040 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2020 | 144 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 98 | 0.040 |
Why?
|
| Male | 7 | 2021 | 350118 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2017 | 12720 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 420 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 677 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2021 | 905 | 0.040 |
Why?
|
| Porosity | 1 | 2020 | 362 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15295 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.040 |
Why?
|
| Nanotubes, Carbon | 1 | 2018 | 73 | 0.040 |
Why?
|
| Mice | 4 | 2021 | 81183 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2017 | 36 | 0.040 |
Why?
|
| Subcutaneous Tissue | 1 | 2017 | 135 | 0.040 |
Why?
|
| Paper | 1 | 2017 | 85 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 427 | 0.040 |
Why?
|
| Tensile Strength | 1 | 2017 | 335 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2017 | 437 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 701 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2017 | 1101 | 0.030 |
Why?
|
| Biotechnology | 1 | 2017 | 281 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2020 | 804 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3870 | 0.030 |
Why?
|
| Pressure | 1 | 2017 | 1203 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4751 | 0.030 |
Why?
|
| Materials Testing | 1 | 2017 | 867 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2018 | 1767 | 0.030 |
Why?
|
| Humans | 11 | 2022 | 744343 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2014 | 137 | 0.030 |
Why?
|
| Potassium | 1 | 2017 | 1336 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2019 | 1299 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1678 | 0.030 |
Why?
|
| Dry Eye Syndromes | 1 | 2017 | 386 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 972 | 0.030 |
Why?
|
| Lung Injury | 1 | 2017 | 436 | 0.030 |
Why?
|
| Sodium | 1 | 2017 | 1623 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10481 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5974 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2017 | 951 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2171 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1294 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1736 | 0.020 |
Why?
|
| Cell Survival | 1 | 2020 | 5882 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3521 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9734 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3582 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13695 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
| Swine | 1 | 2017 | 5917 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3508 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 21683 | 0.010 |
Why?
|
| Female | 3 | 2017 | 380194 | 0.010 |
Why?
|
| Lung | 1 | 2017 | 9856 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9727 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77709 | 0.010 |
Why?
|